Beifuji is the trade name, generic name is topical recombinant bovine basic fibroblast growth factor, the role and efficacy is to promote wound healing, can be used for the treatment of burns, chronic ulcers and other wounds caused by. Topical Recombinant Bovine Basic Fibroblast Growth Factor can improve blood circulation and promote local capillary regeneration of wounds, with the efficacy of promoting wound healing, and can be used for the treatment of shallow second-degree burns, deep second-degree burns, granulomatous wounds, as well as chronic wounds caused by body surface ulcers. In addition, patients with fresh wounds caused by trauma and surgical wounds can also be treated with recombinant bovine basic fibroblast growth factor as prescribed by the doctor. If the patient is allergic to recombinant bovine basic fibroblast growth factor, treatment with the drug should be contraindicated. Adverse effects of the drug are not known. In addition, patients need to treat the wound with debridement and then rinse it with saline before using recombinant bovine basic fibroblast growth factor. The drug needs to be used under the guidance of a doctor and should not be used without authorization.